Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults

References

• de Boer HM Mula M Sander JW The global burden and stigma of epilepsy Epilepsy Behav 2008 12 540 546 18280210
   PubMed Web of Science ®Google Scholar
• Pugliatti M Beghi E Forsgren L Ekman M Sobocki P Estimating the cost of epilepsy in Europe: a review with economic modeling Epilepsia 2007 48 2224 2233 18088267
   PubMed Web of Science ®Google Scholar
• Yoon D Frick KD Carr DA Austin JK Economic impact of epilepsy in the United States Epilepsia 2009 50 2186 2191 19508694
   PubMed Web of Science ®Google Scholar
• Engel JJr A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology Epilepsia 2001 42 796 803 11422340
   PubMed Web of Science ®Google Scholar
• Berg AT Shinnar S Levy SR Testa FM Smith-Rapaport S Beckerman B How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis Epilepsia 2000 41 1269 1275 11051121
   PubMed Web of Science ®Google Scholar
• Brodie MJ Barry SJ Bamagous GA Norrie JD Kwan P Patterns of treatment response in newly diagnosed epilepsy Neurology 2012 78 1548 1554 22573629
   PubMed Web of Science ®Google Scholar
• Kwan P Sander JW The natural history of epilepsy: an epidemiological view J Neurol Neurosurg Psychiatry 2004 75 1376 1381 15377680
   PubMed Web of Science ®Google Scholar
• Noe KH Seizures: diagnosis and management in the outpatient setting Semin Neurol 2011 31 54 64 21321833
   PubMed Web of Science ®Google Scholar
• French JA Kanner AM Bautista J Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society Epilepsia 2004 45 401 409 15101821
   PubMed Web of Science ®Google Scholar
• Glauser T Ben-Menachem E Bourgeois B ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes Epilepsia 2006 47 1094 1120 16886973
   PubMed Web of Science ®Google Scholar
• Schauf CL Zonisamide enhances slow sodium inactivation in Myxicola Brain Res 1987 413 185 188 2439177
   PubMed Web of Science ®Google Scholar
• Schulze-Bonhage A Zonisamide in the treatment of epilepsy Expert Opin Pharmacother 2010 11 115 126 20001433
   PubMed Web of Science ®Google Scholar
• Rock DM Macdonald RL Taylor CP Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant Epilepsy Res 1989 3 138 143 2565229
   PubMed Web of Science ®Google Scholar
• Suzuki S Kawakami K Nishimura S Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex Epilepsy Res 1992 12 21 27 1326433
   PubMed Web of Science ®Google Scholar
• Kito M Maehara M Watanabe K Mechanisms of T-type calcium channel blockade by zonisamide Seizure 1996 5 115 119 8795126
   PubMed Web of Science ®Google Scholar
• Ueda Y Doi T Tokumaru J Willmore LJ Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures Brain Res Mol Brain Res 2003 116 1 6 12941455
   PubMedGoogle Scholar
• Okada M Kaneko S Hirano T Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release Epilepsy Res 1992 13 113 119 1464296
   PubMed Web of Science ®Google Scholar
• Masuda Y Noguchi H Karasawa T Evidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effects Arzneimittelforschung 1994 44 267 269 8192690
   PubMed Web of Science ®Google Scholar
• Leppik IE Zonisamide: chemistry, mechanism of action, and pharmacokinetics Seizure 2004 13 Suppl 1 S5 S9 15511691
   PubMed Web of Science ®Google Scholar
• Peters DH Sorkin EM Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy Drugs 1993 45 760 787 7686468
   PubMed Web of Science ®Google Scholar
• Sills G Brodie M Pharmacokinetics and drug interactions with zonisamide Epilepsia 2007 48 435 441 17319920
   PubMed Web of Science ®Google Scholar
• Matsumoto K Miyazaki H Fujii T Amejima H Furukawa H Hashimoto M Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction Chem Pharm Bull (Tokyo) 1989 37 2807 2810 2611942
   PubMed Web of Science ®Google Scholar
• Kochak GM Page JG Buchanan RA Peters R Padgett CS Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures J Clin Pharmacol 1998 38 166 171 9549648
   PubMed Web of Science ®Google Scholar
• Kothare SV Kaleyias J Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety Expert Opin Drug Metab Toxicol 2008 4 493 506 18433351
   PubMed Web of Science ®Google Scholar
• Okada Y Seo T Ishitsu T Population estimation regarding the effects of cytochrome P450 2C19 and 3A5 polymorphisms on zonisamide clearance Ther Drug Monit 2008 30 540 543 18641551
   PubMed Web of Science ®Google Scholar
• Brodie MJ Ben-Menachem E Chouette I Giorgi L Zonisamide: its pharmacology, efficacy and safety in clinical trials Acta Neurol Scand Suppl 2012 194 19 28 23106522
   PubMedGoogle Scholar
• Griffith SG Dai Y Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women Clin Ther 2004 26 2056 2065 15823769
   PubMed Web of Science ®Google Scholar
• Schmidt D Jacob R Loiseau P Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial Epilepsy Res 1993 15 67 73 8325280
   PubMed Web of Science ®Google Scholar
• Faught E Ayala R Montouris GG Leppik IE Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures Neurology 2001 57 1774 1779 11723262
   PubMed Web of Science ®Google Scholar
• Sackellares JC Ramsay RE Wilder BJ Browne TR3rd Shellenberger MK Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures Epilepsia 2004 45 610 617 15144425
   PubMed Web of Science ®Google Scholar
• Brodie MJ Duncan R Vespignani H Solyom A Bitenskyy V Lucas C Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures Epilepsia 2005 46 31 41
   Web of Science ®Google Scholar
• Naritoku D Dose response efficacy of zonisamide monotherapy during 40 weeks treatment of partial seizures in patients with newly diagnosed epilepsy Epilepsia 2006 47 138 139
   Web of Science ®Google Scholar
• Baulac M Brodie MJ Patten A Segieth J Giorgi L Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial Lancet Neurol 2012 11 579 588 22683226
   PubMed Web of Science ®Google Scholar
• Chadwick DW Marson AG Zonisamide add-on for drug-resistant partial epilepsy Cochrane Database Syst Rev 2005 4 CD001416 16235282
   PubMedGoogle Scholar
• Brodie MJ Zonisamide as adjunctive therapy for refractory partial seizures Epilepsy Res 2006 68 Suppl 2 S11 S16 16316744
   PubMed Web of Science ®Google Scholar
• Mula M Sander JW Negative effects of antiepileptic drugs on mood in patients with epilepsy Drug Saf 2007 30 555 567 17604407
   PubMed Web of Science ®Google Scholar
• Mula M Monaco F Antiepileptic drugs and psychopathology of epilepsy: an update Epileptic Disord 2009 11 1 9 19258231
   PubMed Web of Science ®Google Scholar
• Zaccara G Tramacere L Cincotta M Drug safety evaluation of zonisamide for the treatment of epilepsy Expert Opin Drug Saf 2011 10 623 631 21663459
   PubMed Web of Science ®Google Scholar
• Chung S Wang N Hank N Comparative retention rates and long-term tolerability of new antiepileptic drugs Seizure 2007 16 296 304 17267243
   PubMed Web of Science ®Google Scholar
• Catarino CB Bartolini E Bell GS Yuen AW Duncan JS Sander JW The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre Epilepsy Res 2011 96 39 44 21601427
   PubMed Web of Science ®Google Scholar
• Brodie MJ Perucca E Ryvlin P Ben-Menachem E Meencke HJ Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy Neurology 2007 68 402 408 17283312
   PubMed Web of Science ®Google Scholar
• Kwan P Brodie MJ Kalviainen R Yurkewicz L Weaver J Knapp LE Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial Lancet Neurol 2011 10 881 890 21889410
   PubMed Web of Science ®Google Scholar
• Marinas A Villanueva V Giraldez BG Molins A Salas-Puig J Serratosa JM Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy Epileptic Disord 2009 11 61 66 19264587
   PubMed Web of Science ®Google Scholar
• Mula M Trimble MR Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors CNS Drugs 2009 23 121 137 19173372
   PubMed Web of Science ®Google Scholar
• Wellmer J Wellmer S Bauer J The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy Acta Neurol Scand 2009 119 233 238 19053955
   PubMed Web of Science ®Google Scholar
• Antel J Hebebrand J Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide Handb Exp Pharmacol 2012 209 433 466 22249827
   PubMedGoogle Scholar